Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate

Neuropsychobiology

Volumn 63, Issue 2, 2011, Pages 82-91

  Negrao, Bianca Lee ^a   Bipath, Priyesh ^a   Van Der Westhuizen, Deborah ^a   Viljoen, Margaretha ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Attention deficit hyperactivity disorder; Autonomic nervous system; Focussed attention; Heart rate variability; Methylphenidate; Ritalin; Skin conductivity; Sympathovagal balance

Indexed keywords

METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ADRENERGIC SYSTEM; ARTICLE; ATTENTION DEFICIT DISORDER; AUTONOMIC NERVOUS SYSTEM; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEEDBACK SYSTEM; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERACTIVITY; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHOOL CHILD; SKIN CONDUCTANCE; VAGUS NERVE;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; GALVANIC SKIN RESPONSE; HEART RATE; HUMANS; MALE; METHYLPHENIDATE; REST;

EID: 78650247913     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317548     Document Type: Article

References (40)

1. Panzer A, Viljoen M: Supportive neurodevelopmental evidence for ADHD as a developmental disorder. Med Hypotheses 2005; 64: 755-758.
2. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed 4. Washington, American Psychiatric Association, 2000.
3. ADHASA, South Africa, viewed 20 Jan 2008, ! http://www.adhdsupport.co.za 1 .
4. Mill J: Rodent models: utility for candidate gene studies in human Attention-Deficit Hyperactivity Disorder (ADHD). J Neurosci Methods 2007; 166: 294-305.
5. Sadock BJ, Sadock VA (eds): Kaplan and Sadock's Comprehensive Textbook of Psychiatry, ed 8. Philadelphia, Lippincott, Williams & Wilkins, 2005.
6. Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, Fischman AJ: In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol. Psychiatry 2005; 57: 1293-1300.
7. Hechtman L: Genetic and neurobiological aspects of attention deficit hyperactivity disorder: a review. J Psychiatr Neurosci 1994; 19: 193-201.
8. Levy F: The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust NZJ Psychiatry 1991; 25: 277-283.
9. Oades RD, 1987: Attention-deficit disorder with hyperactivity: the contribution of catecholaminergic activity. Prog Neurobiol 29: 365-391
10. Guimarães AP, Schmitz M, Polanczyk GV, Zeni C, Genro J, Roman T, Rohde LA, Hutz MH: Further evidence for the association between attention deficit/hyperactivity disorder and the serotonin receptor 1B gene. J Neural Transm 2009; 116: 1675-1680.
11. Li J, Wang Y, Zhou R, Wang B, Zhang H, Yang L, Faraone S: Association of attentiondeficit/ hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects. Neurosci Lett 2006; 401: 6-9.
12. Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Faraone S: Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/ hyperactivity disorder in Han Chinese subjects. Neurosci Lett 2006; 407: 107-111. (Pubitemid 44397237)
13. Stadler C, Zepf FD, Demisch L, Schmitt M, Landgraf M, Poustka F: Influence of rapid tryptophan depletion on laboratory-provoked aggression in children with ADHD. Neuropsychobiology 2007; 56: 104-110.
14. Zepf FD, Stadler C, Demisch L, Schmitt M, Landgraf M, Poustka F: Serotonergic functioning and trait-impulsivity in attention- deficit/hyperactivity-disordered boys (ADHD): influence of rapid tryptophan depletion. Hum Psychopharmacol 2008; 23: 43-51.
15. Zepf FD, Holtmann M, Stadler C, Demisch L, Schmitt M, Wöckel L, Poustka F: Diminished serotonergic functioning in hostile children with ADHD: tryptophan depletion increases behavioural inhibition. Pharmacopsychiatry 2008; 41: 60-65.
16. Guimarães AP, Zeni C, Polanczyk GV, Genro JP, Roman T, Rohde LA, Hutz MH: Serotonin genes and attention deficit/hyperactivity disorder in a Brazilian sample: preferential transmission of the HTR2A 452His allele to affected boys. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:69-73.
17. Oades RD: Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder. Behav Brain Res 2002; 130: 97-102.
18. Nigg JT: Neuropsychologic theory and findings in attention-deficit- hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry 2005; 57: 1424-1435.
19. Monastra VJ, Lubar JF, Linden M: The development of a quantitative electroencephalographic scanning process for attention deficit- hyperactivity disorder: reliability and validity studies. Neuropsychology 2001; 15: 136-144.
20. Rossiter T: The effectiveness of neurofeedback and stimulant drugs in treating AD/ HD. 2. Replication. Appl Psychophysiol Biofeedback 2004; 29: 233-243.
21. Beauchaine TP, Katkin ES, Strassberg Z, Snarr J: Disinhibitory psychopathology in male adolescents: discriminating conduct disorder from attention-deficit/hyperactivity disorder through concurrent assessment of multiple autonomic states. J Abnorm Psychol 2001; 110: 610-624.
22. O'Connell RG, Bellgrove MA, Dockree PM, Robertson IH: Reduced electrodermal response to errors predicts poor sustained attention performance in attention deficit hyperactivity disorder. Neuroreport 2004; 15: 2535-2538.
23. Broyd SJ, Johnstone SJ, Barry RJ, Clarke AR, McCarthy R, Selikowitz M: The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder. Int J Psychophysiol 2005; 58: 47-58.
24. Crowell SE, Beauchaine TP, Gatzke-Kopp L, Sylvers P, Mead H, Chipman-Chacon J: Autonomic correlates of attention-deficit/hyperactivity disorder and oppositional defiant disorder in preschool children. J Abnorm Psychol 2006; 115: 174-178.
25. Vles JS, Feron FJ, Hendriksen JG, Jolles J, van Kroonenburgh MJ, Weber WE: Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD). Neuropedicatrics 2003; 34: 77-80.
26. Carboni E, Silvagni A: Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD. Neural Plast 2004; 11: 77-95.
27. Grant CC: Heart rate variability and dysrhythmogenic potential in patients admitted to psychiatric institutions; dissertation, Pretoria, 2005.
28. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-381.
29. Hubeaux K, Deffieux X, Ismael SS, Raibaut P, Amarenco G: Autonomic nervous system activity during bladder filling assessed by heart rate variability analysis in women with idiopathic overactive bladder syndrome or stress urinary incontinence. J Urol 2007; 178: 2483-2487.
30. Lewis MJ, Kingsley M, Short AL, Simpson K: Influence of high-frequency bandwidth on heart rate variability analysis during physical exercise. Biomed Signal Process Control 2007; 2: 34-39.
31. Hallioglu O, Okuyaz C, Mert E, Makharoblidze K: Effects of antiepileptic drug therapy on heart rate variability in children with epilepsy. Epilepsy Res 2008; 79: 49-54.
32. Tsou C, Kao T, Fan K, Wang J, Luk H, Koenig HM: Clinical assessment of propofol-induced yawning with heart rate variability: a pilot study. J Clin Anesth 2008; 20: 25-29.
33. Haensch C, Lerch H, Jörg J, Isenmann S: Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease. Parkinsonism Relat Disord 2009; 15: 134-137.
34. Craig J: The psychoneurological profile of fibromyalgia; dissertation, Pretoria, 2005.
35. Harnod T, Yang CCH, Hisn Y, Shieh K, Wang P, Kuo TBJ: Heart rate variability in children with refractory generalized epilepsy. Seizures 2008; 17: 297-301.
36. Kishore KR, Udupa K, Gangadhar BN, Lavekar GS, Raju TR, Sathyaprabha TN: Differential effect of ayurveda (Indian traditional system of medicine) and tricyclic antidepressants in altering cardiac autonomic functions in patients of major depression: a clinical study with heart rate variability (HRV) measures. J Affect Disord 2008; 107:S53-S122.
37. Castro MN, Vigo DE, Weidema H, Fahrer RD, Chu EM, de Achával D, Nogués M, Leiguarda RC, Cardinali DP, Guinjoan SM: Heart rate variability response to mental arithmetic stress in patients with schizophrenia: autonomic response to stress in schizophrenia. Schizophr Res 2008; 99: 294-303.
38. Schaaf RC, Miller LJ, Seawell D, O'Keefe S: Children with disturbances in sensory processing: a pilot study examining the role of the parasympathetic nervous system. Am J Occup Ther 2003; 57: 442-449.
39. Shibagaki M, Furuya T: Baseline respiratory sinus arrhythmia and heart-rate responses during auditory stimulation of children with attention-deficit hyperactivity disorder. Percept Mot Skills 1997; 84(3 pt 1):967-975.
40. Zepf FD, Holtmann M, Stadler C, Wöckel L, Poustka F: Reduced serotonergic functioning changes heart rate in ADHD. J Neural Transm 2009; 116: 105-108.